AbstractBackground Results from recent, highly debated, retrospective studies raised concerns and prompted considerations about further testing the quality of long stored red blood cells from a biochemical standpoint.Design and Methods We performed an integrated mass spectrometry-based metabolomics and proteomics time-course investigation on SAGM-stored red blood cells. In parallel, structural changes during storage were monitored through scanning electron microscopy.Results We detected increased levels of glycolytic metabolites over the first 2 weeks of storage. From day 14 onwards, we observed a significant consumption of all metabolic species, and diversion towards the oxidative phase of the pentose phosphate pathway. These phenomena coincided with the accumulation of reactive oxygen species and markers of oxidation (protein carbonylation and malondialdehyde accumulation) up to day 28. Proteomics evidenced changes at the membrane protein level from day 14 onwards. Changes included fragmentation of membrane structural proteins (spectrin, band 3, band 4.1), membrane accumulation of hemoglobin, anti-oxidant enzymes (peroxiredoxin-2) and chaperones. While the integrity of red blood cells did not show major deviations at day 14, at day 21 scanning electron microscope images revealed that 50% of the erythrocytes had severely altered shape. We could correlate the scanning electron microscopy observations with the onset of vesiculation, through a proteomics snapshot of the difference in the membrane proteome at day 0 and day 35. We detected proteins involved in vesicle formation and docking to the membrane, such as SNAP alpha.Conclusions Biochemical and structural parameters did not show significant alterations in the first 2 weeks of storage, but then declined constantly from day 14 onwards. We highlighted several parallelisms between red blood cells stored for a long time and the red blood cells of patients with hereditary spherocytosis.
Red blood cell (RBC) concentrates may be stored for up to 42 days under controlled conditions before transfusion. However, there are still concerns about the suitability of older blood units for transfusion purposes. This is especially true for certain categories of recipients, such as traumatized, post-operative and critically ill patients.1 Despite accumulating retrospective evidence of reduced blood viability after the first 2 weeks of storage,2 definitive results from prospective, randomized, double-blind clinical trials are still lacking3,4 or inconclusive. These problems are mainly due to the intrinsic statistical limitations of the experimental models4 or the lack of common methods and shared standards between laboratories.5 A frequent conclusion to the debate has underscored radical questions about the balance of risks and benefits of RBC transfusion.6 Nevertheless, attempts to produce prospective clinical evidence have led to the quasi-philosophical statement that “available data do not support an adequate suspicion that long-stored RBCs may be associated with common adverse morbidity and/or mortality outcomes, so as to justify exposing experimental subjects to the other known or probable, albeit rare, risks of old RBCs”.7
It is beyond the scope of this article to provide a proper clinical answer to the critical question on the quality of long-stored RBC. Here, however, we have performed a multi-faceted investigation of RBC storage trying to support and expand existing knowledge from a mere biochemical perspective. Biochemical approaches have already provided convincing evidence that refrigerated storage causes alterations to RBC, which are only reversible to some extent; these alterations are an array of phenomena which are collectively called the “storage lesion”.8–10
Numerous changes occur in RBC during storage which may irreversibly alter their biological functions, including delivery of oxygen to cells.11 Increases in O2 affinity in stored RBC have been well documented;11,12 these reflect progressive decreases in 2,3-diphosphoglycerate (2,3-DPG) levels over the weeks of storage.12 However, the O2 delivery capacity of transfused RBC that have been stored is deficient even early after processing and before a significant decline in 2,3-DPG.14 Further lesions occur in stored RBC, which have been shown to lose potassium, have depleted ATP stores, and altered lipids and membranes. These lesions result in more rigid cells and reduced oxygen offloading.8–10 The suspending fluid becomes enriched with free hemoglobin and biologically active lipids, along with large quantities of negatively charged microvesicles.14,15 Membrane protein fragmentation16 and accumulation of membrane biomarkers17,18 have also been reported to correlate with storage duration.
In the present study we report an integrated overview of the biochemical processes taking place in RBC during storage. New tests such as metabolomics19 have been performed for the first time on RBC stored in a solution of saline, adenine, glucose and mannitol (SAGM). Recent literature only covers RBC stored in mannitol-adenine-phosphate.20
Design and Methods
This study was approved by the Italian National Blood Centre. The design and methods of the study are outlined below, but further details are provided in the Online Supplementary Design and Methods.
Whole blood (450 mL ± 10%) was collected from healthy volunteer donors into citrate-phosphate-dextrose anticoagulant (63 mL) and leukodepleted. After separation of plasma by centrifugation, RBC were suspended in 100 mL of SAGM additive solution. We studied RBC units collected from eight donors [male = 4, female = 4, age 45±11.5 (mean ± SD)]. RBC units were stored under standard blood bank conditions (1–6 °C) and samples were removed aseptically for the analysis every week from day 0 until day 42 of storage.
Samples from the eight units were extracted and treated as extensively reported in the Online Supplementary Design and Methods19 which also includes details of the high performance liquid chromatography (HPLC) settings, mass spectrometry settings and statistical analysis of the metabolomics results. Results were plotted as fold-change variations upon normalization to day 0 control values, as described by Nishino et al.20
Reactive oxygen species (ROS), protein carbonylation and accumulated malondialdehyde levels were calculated spectrophoto-metrically, as extensively described in the Online Supplementary Design and Methods.
Human erythrocyte membrane and cytosol proteins were extracted on day 0, day 14 and day 35 as previously described,16 with minor modifications, including either the presence or absence of N-ethylmaleimide (NEM) in the extraction protocol to prevent artifactual oxidation of thiol groups21 (further details are provided in the Online Supplementary Design and Methods).
Protein precipitates were prepared as previously reported,16 in the presence or absence of NEM. A total of 250 μL of the resulting protein solution was then used to perform two-dimensional electrophoresis [13 cm long IPG 3-10 NL (Amersham Biosciences) for the first dimension and a 5–16% T gradient sodium dodecylsulfate polyacrylamide gel]. Further experimental details are provided in the Online Supplementary Design and Methods. Proteins were visualized by staining with Coomassie Brilliant Blue G-250 stain.
Ninety-six stained gels (3 technical replicates × 8 biological replicates × 2 groups × 2 periods – day 0 and 35 – with or without NEM) were digitalized and elaborated for among-group comparisons (ANOVA) as previously reported16 and extensively described in the Online Supplementary Design and Methods. Differential protein expression was considered statistically significant for P values less than 0.05 and the change in the photodensity of protein spots between day 0, day 14 and day 35 samples (with or without NEM) had to be more than 2-fold. Moreover, as protein fragments were the main changes to be expected,16 we took into account only protein spots with an apparent molecular weight of below approximately 60 kDa.
Protein spots were carefully excised from stained gels and subjected to in-gel trypsin digestion, as previously reported.16 Peptide mixtures were separated using a nanoflow-HPLC system (Ultimate; Switchos; Famos; LC Packings, Amsterdam, The Netherlands). Mass spectrometry settings and bioinformatic identification details are provided in the Online Supplementary Design and Methods.
Scanning electron microscopic studies of RBC were performed by means of a JEOL JSM 5200 electron microscope. Samples were prepared as described in full in the Online Supplementary Design and Methods. The different cell shapes were identified using Bessis’ classification.22 The percentages of discocytes, echinocytes, sphero-echinocytes, stomatocytes, sphero-stomatocytes, and spherocytes were evaluated by counting 1000 to 1500 cells in randomly chosen fields. Although there is still an open debate about reversible and irreversible shape classification, shape changes were classified as according to Berezina et al.23 According to this classification, RBC manifesting echinocyte and stomatocyte shapes are capable of returning to the discocyte shape under certain conditions. Thus, these RBC shape changes are considered potentially reversible transformations. In contrast, RBC assuming sphero-echinocyte, sphero-stomatocyte, spherocyte, ovalocyte or degenerated shapes are irreversibly changed cells.
Metabolomics, proteomics and scanning electron microscopy (SEM) analyses were performed simultaneously on eight leukodepleted RBC units (residual white blood cell count < 1×10/unit).24 At the end of the storage (42 days), hemolysis was less than 0.8%24 for all the tested products.
It is worth mentioning that the possibility of performing multi-faceted investigations covering both proteomic and metabolomic aspects stems from the sensitivity (down to the fmol level) and specificity of the HPLC and mass spectrometry techniques. Although these approaches are not used routinely in the clinical setting, they are becoming widespread in research laboratories given their versatility and robustness. For example, the integrated metabolomic analysis here was used to perform relative quantification analyses of 12 different metabolites through HPLC-mediated elution of 20 μL of the original sample into the mass spectrometer.
Fold-change variation values upon normalization to day 0 controls are presented in Online Supplementary Figure S1.
Glycolytic phosphate precursors apparently accumulated slightly over the first 2 weeks of storage, as observed for glucose-6-phosphate (G6P)/fructose-6-phosphate (F6P) and glyceraldehyde-3-phosphate (G3P) (Online Supplementary Figure S1). On the other hand, fructose-1,6-diphosphate (FDP) accumulated significantly at day 7. From day 14 onwards the trend was inverted and metabolites were rapidly consumed so that by the end of the storage period they were below (75.6±3.4% for G6P/F6P) or far below (51.4±2.1% for FDP and 29.2±1.4 % for G3P) the initial concentration.
Diphosphoglycerate (DPG) levels followed trends already reported in literature,11,20 with early moderate accumulation up to day 7 and then a constant decrease until day 21 and onwards, at which point the concentrations were as low as 0.05±0.01% of the original day 0 values.
On the other hand, phosphoenolpyruvate (PEP) followed an anomalous trend, with a constant decrease until day 28, at which point we detected a 1.6 ± 0.1 fold increase in almost all the tested units, followed by a reversion so that the levels were lower than day 0 control values by day 42 (0.65 ± 0.04 %).
Lactate, which is a frequently measured parameter in metabolic analyses of RBC,11,20, constantly accumulated as storage progressed, reaching a final 20.39±0.9 fold increase in comparison to day 0 control levels.
In parallel, we observed a moderate, albeit constant accumulation of pentose phosphate pathway intermediates: 6-phosphogluconic acid reached a plateau at day 28, while NADPH levels continued to rise. At day 42 the levels of both metabolites had doubled in comparison to day 0 control levels.
ATP appeared to increase up to day 7 and was then rapidly consumed soon after the first week, so as to reach initial values and below. However, the ATP consumption rate decreased from day 14 to day 21, and from day 21 onwards.
NAD accumulated until day 7, then it decreased constantly until the end of the storage, when we recorded levels 59.99±0.2% lower than the day 0 control level.
Finally, the levels of reduced glutathione (GSH) and oxidized glutathione (GSSG) followed opposing trends. The former decreased constantly over storage so that its levels had halved by day 42, while the latter increased constantly from day 14 onwards (1.56±0.02 fold increase at the end of the storage).
ROS accumulated over the first 3 weeks of storage, to reach a plateau at 21 days (252.4±12.5 units) (Online Supplementary Figure S2A).
Protein carbonylation increased constantly and uniformly in all the tested samples from day 0 (41.3±2.4 mmol/mL) until the fourth week of storage (62.1±2.5 mmol/mL). From the 28 day onwards carbonylation trends seemed to be reversed. Detected protein carbonyls were reduced in almost all of the tested subjects at the end of the storage (48.2 mmol/mL), while in others it reached a plateau with only slight decreases (59 mmol/mL), in agreement with previous observations by Papassideri’s group18 (Online Supplementary Figure S2B).
The malondialdehyde assay demonstrated a progressive and constant accumulation of oxidized lipid markers from 3.4±0.3 mmol/mL at day 0 up to 7.1±0.6 mmol/mL at day 42 (Online Supplementary Figure S2C).
In our previous study on RBC fragmentation during storage we observed an increase of fragments between the second and the fifth weeks. However, that study had some major limitations since the analyses were performed on RBC units that were neither buffy coat-depleted nor leukofiltered.16 Early fragments might, therefore, have been provoked by white blood cells in the unit. On the other hand, when testing leukocyte-filtered RBC concentrates, protein fragments accumulated in the period between the third and fifth weeks, as we could eventually assess. Indeed, in the present study, 2-DE differential analyses between day 0 and day 14 samples highlighted the presence of a limited number of statistically significant differential spots (spot numbers 320, 327 and 342, all identified as protein band 4.1; and spots 389, 402 and 417, identified as peroxiredoxin 2 (Figure 1A2 and Online Supplementary Table 1A). Conversely, significant levels of fragments were observed at day 35 in all the tested units. We, therefore, performed a targeted 2-DE analysis of samples from the eight leukocyte-filtered RBC units at day 0 and day 35 mainly aimed at determining significant variations [P<0.05 ANOVA, |fold-change|> 2.0] in the low molecular weight region, below 60 kDa. Since protein fragments have been supposed to be masked or triggered by artifactual oxidation during sample preparation,21 we decided to perform the 2-DE analysis both in the presence and absence of the alkylating agent NEM. Results for the two arms of the study are reported in Online Supplementary Figure S1A and S1B, respectively.
Results obtained without NEM included the observation of 15 different highly statistically significant protein spots, which were further identified as eight distinct proteins (Online Supplementary Table 1B).
In the presence of NEM, the overall number of spots (at day 0 in comparison to samples without NEM) visibly increased. Although it is beyond the scope of this article to understand the reasons underlying this biochemical phenomenon, it cannot be excluded that NEM-modified proteins could have been hydrolysed to the corresponding N-ethylsuccinimide cysteine residue. This may provide additional protease cleavage sites and thus promote enzyme-mediated protein fragmentation.25 However, the effect was the same in day 0, day 14 and day 35 samples and thus it did not compromise differential analyses. Besides, fragments evidenced at day 35 were the same both in the presence and absence of NEM, while NEM addition only enabled resolution of further non-fragmented proteins, as could be deduced from the relation between the theoretical and the observed molecular weights (Figure 1, and Online Supplementary Table S1). On the other hand, no significant fragmentation was observed in day 14 samples with NEM in comparison to day 0 controls treated with NEM (data not shown).
As for the present study, we determined a significant increase at day 35 against day 0 control gels of 27 differential spots which enabled identification of 33 distinct protein entries (Online Supplementary Table S1B). Notably, all of the protein entries identified without NEM could still be identified upon addition of the alkylating agent, allowing us to confirm that observations made so far on protein fragments16 were not artifactual results from oxidation of thiol groups during preparation steps.
The addition of NEM favored the separation and identification of an increased number of protein spots, which accumulated in the membrane fraction at day 35 in comparison to day 0 controls. Indeed, a comparison of proteins found with NEM and those found without NEM revealed a series of new protein entries. These mainly included proteins which were characterized by thiol groups in their functional/catalytic domain [for example, thioredoxin-like fold (IPR012336) in TXNL1, CLIC1, GSTO1, and GPX1].
These proteins were destined to artifactual over-oxidation during the extraction and their fluctuations ended up being under-estimated in the absence of the alkylating agent NEM, in agreement with previous observations.21,26
Since RBC lack the capacity to synthesize new proteins, the increased number (and increased photodensity) of protein spots in the low molecular weight range of the membrane fraction could be due to either increase in fragmentation events involving higher molecular weight proteins or the migration to the membrane fraction of cytosolic proteins [soluble fraction (GO:0005625)].
Fragmentation of high molecular weight proteins implies the experimental individuation through 2-DE of protein spots, the molecular weight of which might not be lower than expected theoretically from online available databases. A series of proteins could be included in this group (Online Supplementary Table S1): (i) oxidative stress-related enzymes with oxidoreductase activity (GO:0016491) (glutamate—cysteine ligase catalytic subunit isoform a, stress-induced-phosphoprotein 1); (ii) structural proteins [spectrin alpha and beta chains, band 3 and protein 4.1 isoform 6 - structural constituent of cytoskeleton (GO:0005200)]; and (iii) apoptosis-related proteins (ALG-2 interacting protein 1).
Another group of proteins of cytosolic origin became increasingly represented at the membrane fraction of day 35 samples. This group included: (i) structural proteins (stomatin and flotilin-2); (ii) vesicle-related proteins [alpha-soluble NSF attachment protein, alpha SNAP, 55 KDa erythrocyte membrane protein isoform 1 – belonging to the BioCarta pathway “Synaptic Proteins at the Synaptic Junction (h_PDZsPathway)”]; (iii) oxidative stress-related enzymes [glutathione S-transferase omega-1 isoform 1, glutathione peroxidase, thioredoxin-like protein 1 - glutathione metabolism (hsa00480); 6-phosphogluconolactonase, nicotinate phosphoribosyltransferase-like protein, biliverdin-IX beta reductase isozyme I – KEGG pathway: pentose phosphate pathway (hsa00030) and gene ontology: cofactor metabolic process (GO:0051186)]; (iv) chaperones (stress-induced-phosphoprotein 1, DNA-damage inducible protein 2, KIAA0002, T-complex protein 1 subunit beta isoform 1, peptidyl-prolyl cis-trans isomerase FKBP4, HSPC263, Hsc70-interacting protein); and (v) ion channels (nuclear chloride cannel).
Structural analyses: scanning electron microscopy
SEM images were collected and analyzed following the Bessis classification22 and reversible and irreversible membrane shape alterations during storage (from day 7 to day 42) were differentiated as described by Berezina et al.23 The results are reported in Table 1, as mean ± SD of discocytes, cells with reversibly and irreversibly-altered membrane, as percentages of the overall number of cells taken into account in randomly chosen fields (ranging from 1000 to 1500 per subject). While at day 7 the percentage of discocyte RBC was high (75.3±4.1) and the fraction of RBC displaying irreversible modification of the membrane averaged below 10% (9.2±3.5), SEM images on day 42 showed a substantial percentage of RBC with reversible (45.3±3.8) and irreversible (31.0±2.9) membrane alterations (Table 1). Figure 2 shows a detail and an overview of a RBC sample stored for 42 days (Figure 2A and 2C) in comparison with one stored for 28 days (Figure 2B).
Metabolic parameters change rapidly over the first 2 weeks of storage
In this study we simultaneously tested eight units of RBC stored in SAGM under refrigeration for metabolism, oxidative stress and protein parameters and monitored them throughout their shelf-life (42 days).
Sugar-phosphates and their glycolytic metabolites seemed to accumulate during the first week and then began to decrease as storage progressed, so as to reach low or extremely low levels at the end of the third week (Online Supplementary Figure S1).
Consumption of both 1,3 and 2,3 DPG (we could not discriminate between the isomers through mass spectrometry) had already been reported and had been related to the impaired oxygen delivery capacity of RBC upon transfusion.26 Indeed DPG, in association with pH and HCO3-/CO2 modulates the position and shape of the oxygen dissociation curve.27
The rate of glycolysis decreases as pH falls, which is known to occur over storage.14 Another limiting factor should be complete reduction of NAD to NADH. This was confirmed to some extent by our observations, which included both a constant decrease of pH (data not shown) and a decrease of NAD as storage progressed (although we also noted a significant increase of NAD levels in the first week) (Online Supplementary Figure S1). Lactate accumulated over the whole period of storage, suggesting that glycolysis did not stop, or at least was diverted towards the pentose phosphate pathway, since NADPH and 6PG accumulated.
On the other hand, ATP depletion was constant over the whole 42-day period, testifying to an inefficient rate of ATP production. This is relevant in the light of the role of ATP in the maintenance of electrolyte balance by powering sodium-potassium cation pumps. However, Na/K pumps are known to be turned off at 4°C.28 In the present study ATP depletion was associated with impairment of parameters of cell shape, in agreement with other published data.29
Overall, we could conclude that, if metabolism plays a role in RBC storage, it is to sustain RBC energy production during the first 2 weeks and then it is switched to producing metabolites involved in anti-oxidant responses from day 14 onwards.
Oxidative stress: from metabolism to accumulation of reactive oxygen species
Several authors have proposed that oxidative stress might underpin ex vivo aging of RBC.8,9,16 In this study, we found that ROS accumulated, reaching a plateau at day 21 (Online Supplementary Figure S2A). Protein carbonyls and MDA (Online Supplementary Figure S2B,C) also accumulated, in parallel to a decrease in GSH and increase in GSSG levels (Online Supplementary Figure S1).
Conversely, we observed an increase of pentose phosphate pathway oxidative phase metabolic intermediates NADPH and 6PG as storage progressed. 2-DE analyses of NEM-extracted samples indicated relocation to the membrane of the 6PG-limiting enzyme (6-phosphogluconolactonase – Online Supplementary Table S1) and nicotinate phosphoribosyltransferase-like protein, which catalyzes the conversion of nicotinic acid to nicotinic acid mononucleotide and is essential for nicotinic acid to be able to increase cellular NAD levels and prevent oxidative stress of the cells.30 As we detected higher levels of the product metabolites of these enzymes, it is likely that they relocate to the membrane, where they are needed the most.
Other proteins relocated to the membrane were GSH-homeostasis-related enzymes, such as glutathione S-transferase, glutathione peroxidase and thioredoxin-like protein 1 (hsa00480 – KEGG pathway annotation).
Since G3P levels did not increase again with 6PG and NADPH accumulation, we could assume that the non-oxidative phase of the pentose phosphate pathway is somehow inhibited, while the oxidative phase alone is over-activated. This assumption is coherent with the observation by Giardina’s group31 that the ratio of G3P which is produced through glycolysis and the pentose phosphate pathway does not show major fluctuations over storage, though their interesting conclusions were drawn from nuclear magnetic resonance-based data about (C-2 and C-3 derived from C-glucose) G3P levels alone instead of a whole subset of metabolites.
In conclusion, oxidative stress appeared to increase markedly from day 14 to day 21, when it reached maximum levels.
Alterations of red blood cell membrane shape and vesiculation: a timely snapshot through proteomics
Through proteomics we were able to record an increase of oxidative stress-related enzymes in RBC membranes. We detected proteins involved in GSH-homeostasis, which relocated to the membrane already at day 14 (per-oxiredoxin 2 – Figure 1A2 and Online Supplementary Table S1) or later on, at 35 days (Figure 1A,B; Online Supplementary Table S1). Most of these oxidative stress-related proteins, as well as most of the chaperones individuated have been indicated as key regulatory nodes in the protein-protein interaction analysis of the RBC proteome and interactome in the 2010 study by our group,32 as they mapped to the very heart of the “Save or Sacrifice - SOS” sub-network. The “SOS” sub-network represented the top-score result of a bioinformatic processing cataloguing all the RBC proteins discovered so far based on the relevance of their role in sustaining RBC survival and functionality.
We could not conclude whether this enrichment of oxidative stress-related proteins might be due to an increased necessity to face oxidative stress in the membrane region or rather these no-longer functional proteins are relocated to the membrane through the docking of vesicles prior to their extrusion from the cell. However, the former hypothesis seems reasonable in the light of recent observations by our group which clearly indicate that membrane peroxiredoxin-2 in RBC that have been stored for a long time is still functional.17
The likely effect of oxidative stress at the membrane protein level appeared not only to be limited to an increase in carbonyl levels (Online Supplementary Figure S2B), but also to an increase in fragmentation of structural proteins [spectrin alpha and beta chains, band 3 and protein 4.1 isoform 6 - structural constituent of cytoskeleton (GO:0005200)]. Fragments of band 4.1 were found at the membrane already at day 14 (Figure 1A2). This is in agreement with SEM analyses, which highlighted that significant membrane alterations had accumulated already by day 14 (approximately 45% of RBC showed membrane alterations) and continued to accumulate as storage progressed (by day 35 over 65% of the examined RBC displayed relevant alterations of membrane shape).
In the presence of the alkylating agent NEM during the extraction we detected, through 2-DE, differential photo-densities for those protein spots containing oxidation-sensitive thiol groups, which are otherwise artifactually oxidized during the extraction protocol.21,25,26 Notably enough, a series of proteins involved in vesiculation were detected, such as alpha SNAP and 55 kDa erythrocyte membrane protein isoform 1 (h_PDZsPathway - Biocarta annotation). The former, in particular, is known to play a pivotal role in the process of exocytosis, as it mediates vesicle docking to the membrane also, but not uniquely, in a calcium-dependent manner.33 Since internal Ca is subjected to metabolic control via an ATP-dependent extrusion mechanism (Ca pump),33,34 the decreased ATP content occurring during red cell aging should lead to a raised cellular Ca. This has been reported in the literature from studies that used the fluorescent probe Fura-2 in cells separated on Percoll density gradients, which revealed that in vivo aged RBC (senescent) contained a higher content of free Ca (almost four times higher) than the younger cells.35 The consistency of the role of Ca in the frame of RBC storage is strengthened by the consideration about the role of this ion in modulating the Ca-dependent K channel36 and the influence on RBC membrane shape.37,38
Most of the proteins detected through our 2-DE approach, both in the presence and absence of NEM, had already been reported to accumulate in RBC-leaked micro-and nano-vesicles, for example stomatin, ankyrin, biliverdin reductase, and 14-3-3 zeta/delta (Online Supplementary Table S1 in comparison to the findings of Bosman et al.15), just to mention few.
The list included fragments of structural proteins, among which the cytosolic domain of band 3 deserves a special mention since it is known to represent a “respiratory metabolon” docking site at the RBC membrane,39 and is also found in RBC vesicles.15
Red blood cell storage: parallelism with hereditary spherocytosis
Among the observed membrane anomalies that we could relate to the progression of storage, we evidenced an increased osmotic fragility of long-stored RBC (data not shown). It has long been known that hereditary spherocytosis is correlated with elevated osmotic fragility.40 Hereditary spherocytosis is a hemolytic anemia characterized by the production of sphere-shaped rather than biconcave disk-shaped RBC; these sphere-shaped RBC have an increased tendency to hemolysis because of a decreased surface/volume ratio, which results in a reduced capacity to face increased osmotic stresses.
Our SEM results, in agreement with data in the literature,23 support the characterization of progressive membrane-targeting storage lesions, which end up severely altering RBC shape (Online Supplementary Table S1). Moreover, a recent proteomic investigation on RBC from patients suffering from hereditary spherocytosis concluded that these patients’ cells were characterized by altered redox-regulation, nucleotide metabolism, protein aggregation and/or degradation, cytoskeletal disorganization and severe oxidative stress.41 In particular, Rocha et al.42 reported that peroxiredoxin 2 located at the membrane in RBC from patients with hereditary spherocytosis concomitantly with an increase in oxidative stress. As we had previously observed17 through western blotting studies, and confirmed here by 2-DE (Figure 1A, Online Supplementary Table S1A), peroxiredoxin-2 relocated progressively at the membrane level from the third week to the end of the storage.
Hemoglobin chains have been shown to bind to the RBC membrane in hereditary spherocytosis,43 but also in long-stored RBC in a previously published study9 and in the present study (Online Supplementary Table S1A,B).
Protein degradation at the membrane level was previously reported to begin at day 14 and reach a maximum at day 33.16 Here we observed a significant accumulation of fragments of a series of structural proteins at day 35 (spectrin alpha and beta chains, band 3 and protein 4.1 isoform 6 - structural constituent of cytoskeleton – Online Supplementary Table S1A,B), as a further parallelism between prolonged storage and hereditary spherocytosis in which mutations/fragmentation events targeting these very same proteins have been reported.44,45
Finally, oxidative stress seems to represent another pattern in common with hereditary spherocytosis, as we noted increases in both ROS and protein carbonylation (Online Supplementary Figure S2A,B), peaking at days 21 and 28, respectively. Lipid oxidation was also observed, through the accumulation of MDA (Online Supplementary Figure S2C).
Storage lesions stem from a domino of events leading to the accumulation of irreversible alterations in long-stored RBC. While clinical concerns about the safety and effectiveness of such RBC are still under evaluation, biochemical information is broadly available, although not conclusive. In this context, we performed the current integrated metabolomic and proteomic study to further explore the dynamics of the phenomena underlying RBC storage.
The present study shows that, from biochemical and molecular standpoints, the parameters defining the integrity of SAGM-stored leukodepleted RBC might be still acceptable within the first 14 days of storage but then begin to decline slowly from day 21 and onwards. This information might be relevant with regards to clinical transfusion practices, further fueling the debate about the safety and effectiveness of RBC concentrates stored for longer than 14 days.2 In other terms, if we evaluated RBC-based transfusion therapies with the same strict rules regulating drug interventions, in the light of present findings we could easily conclude that RBC units as a therapeutic product do not preserve their integrity over the whole duration of the storage period, especially from day 14 onwards, this likely resulting in compromised safety and effectiveness.
All the tested parameters appeared to be modified during storage as they are in RBC from patients with hereditary spherocytosis. Indeed, membrane structural protein fragmentation, accumulation of anti-oxidant enzymes and chaperones in the membrane district, as well as the increase in ROS, protein carbonylation and MDA accumulation are all representative of significant, prolonged exposure to oxidative stress in ex vivo RBC. Based on this evidence, it will be interesting to evaluate alternative storage strategies which envisage cold storage of RBC concentrates under anaerobic conditions in order to tackle the accumulation of oxidative stress.
- ↵* The authors contributed equally to this manuscript and share the first authorship.
- Funding: ADA, GMDA and LZ are supported by the Italian National Blood Center (Centro Nazionale Sangue - CNS - Istituto Superiore Sanità - Rome, Italy).
- The online version of this article has a Supplementary Appendix.
- Authorship and Disclosures The information provided by the authors about contributions from persons listed as authors and in acknowledgments is available with the full text of this paper at www.haematologica.org.
- Financial and other disclosures provided by the authors using the ICMJE (www.icmje.org) Uniform Format for Disclosure of Competing Interests are also available at www.haematologica.org.
- Received July 13, 2011.
- Revision received September 21, 2011.
- Accepted September 23, 2011.
- Lelubre C, Piagnerelli M, Vincent JL. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality?. Transfusion. 2009; 49(7):1384-94. PubMedhttps://doi.org/10.1111/j.1537-2995.2009.02211.xGoogle Scholar
- Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008; 358:1229-39. PubMedhttps://doi.org/10.1056/NEJMoa070403Google Scholar
- Steiner ME, Assmann SF, Levy JH, Marshall J, Pulkrabek S, Sloan SR. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci. 2010; 43(1):107-16. PubMedhttps://doi.org/10.1016/j.transci.2010.05.014Google Scholar
- Bennett-Guerrero E, Stafford-Smith M, Waweru PM, Bredehoeft SJ, Campbell ML, Haley NR. A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients. Transfusion. 2009; 49(7):1375-83. PubMedhttps://doi.org/10.1111/j.1537-2995.2009.02152.xGoogle Scholar
- Hess JR. Improving the predictive value of red blood cell storage trials: lessons from the Biomedical Excellence for Safer Transfusion (BEST) Collaborative Trial 41. Transfusion. 2011; 51(1):34S-37S. PubMedhttps://doi.org/10.1111/j.1537-2995.2010.02961.xGoogle Scholar
- Adamson JW. New blood, old blood, or no blood?. N Engl J Med. 2008; 358(12):1295-6. PubMedhttps://doi.org/10.1056/NEJMe0800520Google Scholar
- Vamvakas EC. Meta-analysis of clinical studies of the purported deleterious effects of “old” (versus “fresh”) red blood cells: are we at equipoise?. Transfusion. 2010; 50(3):600-10. PubMedGoogle Scholar
- Lion N, Crettaz D, Rubin O, Tissot JD. Stored red blood cells: a changing universe waiting for its map(s). J Proteomics. 2010; 73(3):374-85. PubMedhttps://doi.org/10.1016/j.jprot.2009.11.001Google Scholar
- Antonelou MH, Kriebardis AG, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol. Transfusion. 2010; 50(2):376-89. PubMedhttps://doi.org/10.1111/j.1537-2995.2009.02449.xGoogle Scholar
- Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang. 2009; 96(2):93-103. PubMedhttps://doi.org/10.1111/j.1423-0410.2008.01117.xGoogle Scholar
- Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, Ortel TL, Reid TS. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA. 2007; 104(43):17063-8. PubMedhttps://doi.org/10.1073/pnas.0708160104Google Scholar
- Valeri CR, Hirsch NM. Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med. 1969; 73(5):722-33. PubMedGoogle Scholar
- Valtis DJ. Defective gas-transport function of stored red blood-cells. Lancet. 1954; 266(6803):119-24. PubMedGoogle Scholar
- Hess JR. Red cell changes during storage. Transfus Apher Sci. 2010; 43(1):51-9. PubMedhttps://doi.org/10.1016/j.transci.2010.05.009Google Scholar
- Bosman GJ, Lasonder E, Luten M, Roerdinkholder-Stoelwinder B, Novotný VM, Bos H. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion. 2008; 48(5):827-35. PubMedGoogle Scholar
- D’Amici GM, Rinalducci S, Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res. 2007; 6(8):3242-55. PubMedhttps://doi.org/10.1021/pr070179dGoogle Scholar
- Rinalducci S, D’Amici GM, Blasi B, Vaglio S, Grazzini G, Zolla L. Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions. Transfusion. 2011; 51(7):1439-49. PubMedhttps://doi.org/10.1111/j.1537-2995.2010.03032.xGoogle Scholar
- Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med. 2007; 11(1):148-55. PubMedhttps://doi.org/10.1111/j.1582-4934.2007.00008.xGoogle Scholar
- D’Alessandro A, Gevi F, Zolla L. A robust high resolution reversed-phase HPLC strategy to investigate various metabolic species in different biological models. Mol Biosyst. 2011; 7(4):1024-32. PubMedhttps://doi.org/10.1039/c0mb00274gGoogle Scholar
- Nishino T, Yachie-Kinoshita A, Hirayama A, Soga T, Suematsu M, Tomita M. In silico modeling and metabolome analysis of long-stored erythrocytes to improve blood storage methods. J Biotechnol. 2009; 144(3):212-23. PubMedhttps://doi.org/10.1016/j.jbiotec.2009.08.010Google Scholar
- Low FM, Hampton MB, Peskin AV, Winterbourn CC. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood. 2007; 109(6):2611-7. PubMedhttps://doi.org/10.1182/blood-2006-09-048728Google Scholar
- Bessis M. Red cell shapes. An illustrated classification and its rationale. Nouv Rev Fr Hematol. 1972; 12(6):721-45. PubMedGoogle Scholar
- Berezina TL, Zaets SB, Morgan C, Spillert CR, Kamiyama M, Spolarics Z. Influence of storage on red blood cell rheo-logical properties. J Surg Res. 2002; 102(1):6-12. PubMedhttps://doi.org/10.1006/jsre.2001.6306Google Scholar
- Recommendation No. R (95) 15. Council of Europe; 2011. Google Scholar
- Gehring H, Christen P. A diagonal procedure for isolating sulfhydryl peptides alkylated with N-ethylmaleimide. Anal Biochem. 1980; 107(2):358-61. PubMedhttps://doi.org/10.1016/0003-2697(80)90396-6Google Scholar
- Ito T, Yamakuchi M, Lowenstein CJ. Thioredoxin increases exocytosis by denitrosylating N-ethylmaleimide-sensitive factor. J Biol Chem. 2011; 286(13):11179-84. PubMedhttps://doi.org/10.1074/jbc.M110.201780Google Scholar
- Rouault C. Red cell oxygen delivery. Effect of 2,3-diphosphoglycerate. Postgrad Med. 1973; 53(3):201-3. PubMedGoogle Scholar
- Wallas CH. Sodium and potassium changes in blood bank stored human erythrocytes. Transfusion. 1979; 19(2):210-5. PubMedhttps://doi.org/10.1046/j.1537-2995.1979.19279160297.xGoogle Scholar
- Haradin AR, Weed RI, Reed CF. Changes in physical properties of stored erythrocytes: Relationship to survival in vivo. Transfusion. 1969; 9(5):229-37. PubMedhttps://doi.org/10.1016/S0372-1248(66)80078-4Google Scholar
- Hara N, Yamada K, Shibata T, Osago H, Hashimoto T, Tsuchiya M. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribo-syltransferase in human cells. J Biol Chem. 2007; 282(34):24574-82. PubMedhttps://doi.org/10.1074/jbc.M610357200Google Scholar
- Messana I, Ferroni L, Misiti F, Girelli G, Pupella S, Castagnola M, Zappacosta B, Giardina B. Blood bank conditions and RBCs: the progressive loss of metabolic modulation. Transfusion. 2000; 40(3):353-60. PubMedhttps://doi.org/10.1046/j.1537-2995.2000.40030353.xGoogle Scholar
- D’Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: an update. J Proteome Res. 2010; 9(1):144-63. PubMedhttps://doi.org/10.1021/pr900831fGoogle Scholar
- Barnard RJ, Morgan A, Burgoyne RD. Domains of alpha-SNAP required for the stimulation of exocytosis and for N-ethyl-malemide-sensitive fusion protein (NSF) binding and activation. Mol Biol Cell. 1996; 7(5):693-701. PubMedhttps://doi.org/10.1091/mbc.7.5.693Google Scholar
- Romero PJ, Romero EA. The role of calcium metabolism in human red blood cell ageing: a proposal. Blood Cells Mol Dis. 1999; 25(1):9-19. PubMedhttps://doi.org/10.1006/bcmd.1999.0222Google Scholar
- Schatzmann HJ. ATP-dependent Ca21-extrusion from human red cells. Experientia. 1966; 22:364-5. PubMedhttps://doi.org/10.1007/BF01901136Google Scholar
- Romero PJ. The role of membrane-bound Ca in ghost permeability to Na and K. J Membrane Biol. 1976; 29(4):329-43. PubMedhttps://doi.org/10.1007/BF01868969Google Scholar
- Palek J, Stewart G, Lionetti FJ. The dependence of shape of human erythrocyte ghosts on calcium, magnesium and adenosine triphosphate. Blood. 1974; 44(4):583-97. PubMedGoogle Scholar
- LaCelle PL, Kirkpatrick FH, Udkow MP, Arkin B. Membrane fragmentation and Ca11-membrane interaction: potential mechanism of shape change in the senescent red cell. Nouv Rev Fr Hemat. 1972; 12:789-98. Google Scholar
- Low PS, Rathinavelu P, Harrison ML. Regulation of glycolysis via reversible enzyme binding to the membrane protein, band 3. J Biol Chem. 1993; 268:14627-31. PubMedGoogle Scholar
- Korones D, Pearson HA. Normal erythrocyte osmotic fragility in hereditary spherocytosis. J Pediatr. 1989; 114(2):264-6. PubMedhttps://doi.org/10.1016/S0022-3476(89)80794-2Google Scholar
- Saha S, Ramanathan R, Basu A, Banerjee D, Chakrabarti A. Elevated levels of redox regulators, membrane bound globin chains and cytoskeletal protein fragments in hereditary spherocytosis erythrocyte proteome. Eur J Haematol. 2011; 87(3):259-66. PubMedhttps://doi.org/10.1111/j.1600-0609.2011.01648.xGoogle Scholar
- Rocha S, Vitorino RM, Lemos-Amado FM, Castro EB, Rocha-Pereira P, Barbot J. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis. 2008; 41(1):5-9. PubMedhttps://doi.org/10.1016/j.bcmd.2008.02.008Google Scholar
- Gallagher PG, Forget BG. Hematologically important mutations: spectrin and ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis. 1998; 24(4):539-43. PubMedhttps://doi.org/10.1006/bcmd.1998.0217Google Scholar
- Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008; 372(9647):1411-26. PubMedhttps://doi.org/10.1016/S0140-6736(08)61588-3Google Scholar
- Messana I, Misiti F, el-Sherbini S, Giardina B, Castagnola M. Quantitative determination of the main glucose metabolic fluxes in human erythrocytes by 13C- and 1H-MR spectroscopy. J Biochem Biophys Methods. 1999; 39(1–2):63-84. PubMedhttps://doi.org/10.1016/S0165-022X(99)00005-6Google Scholar